GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entheon Biomedical Corp (XCNQ:ENBI) » Definitions » Research & Development

Entheon Biomedical (XCNQ:ENBI) Research & Development : C$0.00 Mil (TTM As of Aug. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Entheon Biomedical Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Entheon Biomedical's Research & Development for the three months ended in Aug. 2024 was C$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Aug. 2024 was C$0.00 Mil.


Entheon Biomedical Research & Development Historical Data

The historical data trend for Entheon Biomedical's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entheon Biomedical Research & Development Chart

Entheon Biomedical Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Nov21 Nov22 Nov23
Research & Development
Get a 7-Day Free Trial - - 1.21 1.20 -

Entheon Biomedical Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Entheon Biomedical Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Entheon Biomedical  (XCNQ:ENBI) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Entheon Biomedical Research & Development Related Terms

Thank you for viewing the detailed overview of Entheon Biomedical's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Entheon Biomedical Business Description

Traded in Other Exchanges
Address
999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5
Entheon Biomedical Corp is a biotechnology research and development company committed to treat addiction and substance use disorders.
Executives
Brian Jahns Senior Officer

Entheon Biomedical Headlines

No Headlines